Discover more insights into Sars Cov 2 Nucleocapsid

Keywords frequently search together with Sars Cov 2 Nucleocapsid

Narrow sentence examples with built-in keyword filters

Sars Cov 2 Nucleocapsid sentence examples within receptor binding domain



Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)



Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals


Sars Cov 2 Nucleocapsid sentence examples within enzyme linked immunosorbent



Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19



Parallel detection of SARS-CoV-2 RNA and nucleocapsid antigen in nasopharyngeal specimens from a COVID-19 patient screening cohort


Sars Cov 2 Nucleocapsid sentence examples within rapid affinity pair



Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins.



Developing a SARS-CoV-2 antigen test using engineered affinity proteins



Learn more from Sars Cov 2 Nucleocapsid


Sars Cov 2 Nucleocapsid sentence examples within 2 spike protein



Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform



Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform


Sars Cov 2 Nucleocapsid sentence examples within single molecule array



Quantifying SARS-CoV-2 nucleocapsid antigen in oropharyngeal swabs using single molecule array technology



Quantifying SARS-Cov-2 Nucleocapsid Antigen in Oropharyngeal Swabs Using Single Molecule Array Technology


Sars Cov 2 Nucleocapsid sentence examples within viral life cycle



Structural basis of anti-SARS-CoV-2 activity of hydroxychloroquine: specific binding to NTD/CTD and disruption of LLPS of N protein



Structural basis of anti-SARS-CoV-2 activity of HCQ: specific binding to N protein to disrupt its interaction with nucleic acids and LLPS



Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score



SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production



Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)



SARS-CoV-2 Infects Syncytiotrophoblast and Activates Inflammatory Responses in the Placenta



Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals



Clinical and Virological Response to a Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19



Viewing SARS-CoV-2 Nucleocapsid Protein in Terms of Molecular Flexibility



A Novel Rapid Test to Detect Anti-SARS-CoV-2 N Protein IgG Based on Shear Horizontal Surface Acoustic Wave (SH-SAW)



High Initial Titres of Anti-Spike Antibodies following SARS-CoV-2 Infection is Associated with Faster Decay Rates at Four Months Follow-Up



The importance of determining SARS-CoV-2 N-Ag serodiagnostics for the management of COVID-19 pneumonia in hospital settings


More Sars Cov 2 Nucleocapsid sentence examples
10.1021/acs.jproteome.1c00391

Mass Spectrometric Analysis of Urine from COVID-19 Patients for Detection of SARS-CoV-2 Viral Antigen and to Study Host Response


More Sars Cov 2 Nucleocapsid sentence examples
10.1016/j.eclinm.2021.101172

Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe



Membraneless organelles restructured and built by pandemic viruses: HIV-1 and SARS-CoV-2



Development of a Nucleocapsid Protein-Based ELISA for Detection of Human IgM and IgG Antibodies to SARS-CoV-2



Antibody titers decline 3-month post-vaccination with BNT612b2



Analysing the impact of the two most common SARS-CoV-2 nucleocapsid protein variants on interactions with membrane protein in silico



Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab



Temperature responsive smart polymer for enabling affinity enrichment of current coronavirus (SARS-CoV-2) to improve its diagnostic sensitivity



Durability of SARS-CoV-2-specific IgG responses in saliva for up to 8 months after infection



Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection



Cardiac Fibrosis Is a Risk Factor for Severe COVID-19



Gold nanoparticle based plasmonic sensing for the detection of SARS-CoV-2 nucleocapsid proteins


More Sars Cov 2 Nucleocapsid sentence examples
10.12688/WELLCOMEOPENRES.16890.1

Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana



Cutaneous lymphocytic vasculitis after administration of COVID‐19 mRNA vaccine


More Sars Cov 2 Nucleocapsid sentence examples
10.1016/j.jneuroim.2021.577728

The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases



SARS-CoV-2 nucleocapsid protein impairs stress granule formation to promote viral replication



Automatic label-free immunoassay with high sensitivity for rapid detection of SARS-CoV-2 nucleocapsid protein based on chemiluminescent magnetic beads



Electrochemical sensing of SARS-CoV-2 amplicons with PCB electrodes


More Sars Cov 2 Nucleocapsid sentence examples
10.26434/chemrxiv.14442785.v1

Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins.



Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates



Lofgren syndrome in close temporal association with mild COVID-19 – Case report



[Clinical and morphological characteristics of SARS-CoV-2-related myocarditis proven by the presence of viral RNA and proteins in myocardial tissue].



Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection



The Meaning of SARS-CoV-2 Antibodies in a Patient with a Systemic Reaction to the mRNA-1273 SARS-CoV-2 Vaccine after Previous Natural Immunization


More Sars Cov 2 Nucleocapsid sentence examples
10.26434/CHEMRXIV.14471244.V1

Exponential Amplification Using Photoredox Autocatalysis



A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance



Serum Biomarkers Predict Symptom Duration in Long Term COVID-19 Across a Diverse Population



Trends of SARS-CoV-2 antibody prevalence in selected regions across Ghana



Identification of natural SARS-CoV-2 infection in seroprevalence studies among vaccinated populations



Ultra-fast, high throughput and inexpensive detection of SARS-CoV-2 seroconversion


More Sars Cov 2 Nucleocapsid sentence examples
10.1016/j.jviromet.2021.114183

Development of an immunochromatographic kit to detect severe acute respiratory syndrome coronavirus 2


More Sars Cov 2 Nucleocapsid sentence examples
10.12688/gatesopenres.13357.1

Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression.



Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabs


More Sars Cov 2 Nucleocapsid sentence examples
10.1016/j.envres.2021.111374

Targeted wastewater surveillance of SARS-CoV-2 on a university campus for COVID-19 outbreak detection and mitigation



A Single Drop of Fingerstick Blood for Quantitative Antibody Response Evaluation After SARS-CoV-2 Vaccination



A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance



Are RNA-Based Tests Sufficient for COVID-19 Diagnosis? An Inspiration of Three Asymptomatic Cases



SARS-CoV-2 nucleocapsid protein dually regulates innate immune responses



A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques



Evaluation of SARS-CoV-2 rapid antigen diagnostic tests for saliva samples



Correlation of SARS-CoV-2 Nucleocapsid Antigen and RNA Concentrations in Nasopharyngeal Samples from Children and Adults Using an Ultrasensitive and Quantitative Antigen Assay



Unleashing immuno-mass spectrometry superpowers to detect SARS-CoV-2



B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19



Evaluation of the genalyte maverick SARS-CoV-2 multi-antigen serology panel



Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody



SARS-CoV-2 Nucleocapsid Plasma Antigen for Diagnosis and Monitoring of COVID-19



COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively



Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells



SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic


More Sars Cov 2 Nucleocapsid sentence examples
10.1080/14760584.2021.1977630

Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh



Exponential Amplification Using Photoredox Autocatalysis.



Eastern Cape Healthcare Workers Acquisition of SARS-CoV-2 (ECHAS): Cross-Sectional (Nested Cohort) Study Protocol



Differential Antibody Response to SARS-CoV-2 Antigens in Recovered and Deceased Iranian COVID-19 Patients.



Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam



Laboratory follow-up of convalescent plasma treatment in B-cell depleted patients with COVID-19 pneumonia



Expression and purification of recombinant SARS-CoV-2 nucleocapsid protein in inclusion bodies and its application in serological detection



SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021


More Sars Cov 2 Nucleocapsid sentence examples
10.1016/S2214-109X(21)00355-7

High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort



Just Seeing Is Not Enough for Believing: Immunolabelling as Indisputable Proof of SARS-CoV-2 Virions in Infected Tissue



Development and Clinical Evaluation of an Immunochromatography-Based Rapid Antigen Test (GenBody™ COVAG025) for COVID-19 Diagnosis



Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers



Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan



Longitudinal observation of antibody responses after SARS-CoV-2 infection at 14 months


More Sars Cov 2 Nucleocapsid sentence examples
10.4049/immunohorizons.2100011

One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses



Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities



Serologic Screening of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Cats and Dogs during First Coronavirus Disease Wave, the Netherlands



Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19



Evidence for Deleterious Antigenic Imprinting in SARS-CoV-2 Immune Response



Magnetic Bead-Based Immunoassay Allows Rapid, Inexpensive, and Quantitative Detection of Human SARS-CoV-2 Antibodies


More Sars Cov 2 Nucleocapsid sentence examples
10.1371/journal.pone.0252628

Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform



Highly sensitive and ultra-rapid antigen-based detection of SARS-CoV-2 using nanomechanical sensor platform



Saudi Arabian SARS-CoV-2 genomes implicate a mutant Nucleocapsid protein in modulating host interactions and increased viral load in COVID-19 patients



Histologic and Immunohistochemical Evaluation of 65 Placentas from Women with Polymerase Chain Reaction-proven Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.



The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region



Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients



Developing a SARS-CoV-2 antigen test using engineered affinity proteins



Microfluidic Magneto Immunosensor for Rapid, High Sensitivity Measurements of SARS-CoV-2 Nucleocapsid Protein in Serum



Recombinant SARS-CoV-2 Nucleocapsid Protein: Expression, Purification, and Its Biochemical Characterization and Utility in Serological Assay Development to Assess Immunological Responses to SARS-CoV-2 Infection


Learn more from Sars Cov 2 Nucleocapsid


Sars Cov 2 Nucleocapsid
Encyclopedia